A DSIP fusion protein: manufacturing and a drug-induced sleep assay
Researchers expressed a fusion containing DSIP, albumin and a transduction domain in yeast, then tested it in a mouse sedative assay.
Preclinical studyPaper year: 2017DSIP fusion protein
01 / DESIGN
What was studied?
Researchers expressed a fusion containing DSIP, albumin and a transduction domain in yeast, then tested it in a mouse sedative assay.
02 / FINDINGS
What did the researchers report?
The purified fusion altered latency and duration of pentobarbital-associated sleep in the experimental model.
03 / INTERPRETATION
What are the limits?
A fusion protein is not free DSIP. Potentiating a sedative in mice does not establish normal sleep quality, treatment of insomnia or safe human use.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.
RESEARCH CONTEXT
These are original reading notes on published studies, not product testimonials. Clinical studies used their own pharmaceutical formulations and protocols; their findings do not establish the safety, efficacy or equivalence of materials in our catalog. No personal-use or treatment guidance is provided.
